Systemic lupus erythematosus (SLE) occurs predominantly in women, and hormones may play a role in its etiology. This study was carried out to examine associations between female reproductive and menopausal factors and the development of SLE.
Methods
A cohort of 238,308 women was prospectively examined. Subjects were older women (ages 30-55 years at start) and younger women (ages 25-42 years at start) from the Nurses' Health Study (NHS) and NHSII cohorts. Incident SLE diagnosed between 1976 and 2003 was confirmed by medical record review. The relative risk (RR) of SLE was estimated separately in each cohort using Cox proportional hazards models, and then pooled using meta-analysis random effects models.
Results
Two hundred sixty-two incident cases of SLE were confirmed among the women. In multivariable models adjusted for reproductive and other risk factors, age<or=10 years at menarche (pooled RR 2.1, 95% confidence interval [95% CI] 1.4-3.2), oral contraceptive use (pooled RR 1.5, 95% CI 1.1-2.1), and use of postmenopausal hormones (RR 1.9, 95% CI 1.2-3.1) significantly increased the risk of SLE. An elevation of SLE risk was observed among postmenopausal women primarily after surgical menopause (RR 2.3, 95% CI 1.2-4.5), and also among women with earlier age at natural menopause (P for trend<0.05). Menstrual irregularity was associated with an increased risk of SLE among women in the younger (NHSII) cohort. Age at first birth, parity, and total duration of breastfeeding were not associated with SLE.
Conclusion
Early age at menarche, oral contraceptive use, early age at menopause, surgical menopause, and postmenopausal use of hormones were each associated with an increased risk of SLE. These associations may point to the mechanisms underlying the pathogenesis of SLE.
oral contraceptives systemic lupus risk, early menarche autoimmune disease, surgical menopause lupus erythematosus, postmenopausal hormone therapy sle, reproductive factors autoimmune risk, hormonal contraception immunological effects, estrogen exposure lupus, menstrual irregularity autoimmune, nurses health study hormones, prospective cohort reproductive health
Cite this article
Costenbader, K. H., Feskanich, D., Stampfer, M. J., & Karlson, E. W. (2007). Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. *Arthritis and rheumatism*, *56*(4), 1251-1262. https://doi.org/10.1002/art.22510
Costenbader KH, Feskanich D, Stampfer MJ, Karlson EW. Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. Arthritis Rheum. 2007;56(4):1251-1262. doi:10.1002/art.22510
Costenbader, K. H., et al. "Reproductive and menopausal factors and risk of systemic lupus erythematosus in women." *Arthritis and rheumatism*, vol. 56, no. 4, 2007, pp. 1251-1262.
Veisy A et al., 2015
Open Access
Asian Pacific Journal of Cancer Prevention : APJCP
More than one million new patients suffer from breast cancer annually in the world. In developed countries, breast cancer is the most common malignancy diagnosed among women, and in developing regions...
Objective: To assess whether the risk of incident systemic lupus erythematosus (SLE) is associated with the use of combined oral contraceptives (COCs), because studies of the link between exogenous ho...
Larsen SV et al., 2023
Open Access
JAMA Psychiatry
Importance: Hormonal sensitivity may contribute to the risk of depression in some women, as observed during the premenstrual, postpartum, and perimenopausal phases, and when initiating hormonal contra...
Alonso-Molero J et al., 2022Menopause (New York, N.Y.)
Objective: To extend knowledge about the long-term use of hormones in hormone therapy or oral contraception as prognostic factors in breast cancer.
Methods: The MCC-Spain project is a cohort of 1,685 ...
Contraception/Comparison > Side Effects > Hormonal ContraceptionContraception/Comparison > FABM vs Hormonal > Side EffectsGeneral OB/GYN > Epidemiology > Trends